T. Rowe Price Investment Management, Inc. Haemonetics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,010,957 shares of HAE stock, worth $74.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,010,957
Previous 1,594,867
36.61%
Holding current value
$74.3 Million
Previous $119 Million
58.59%
% of portfolio
0.03%
Previous 0.08%
Shares
9 transactions
Others Institutions Holding HAE
# of Institutions
339Shares Held
50.4MCall Options Held
666KPut Options Held
395K-
Black Rock Inc. New York, NY5.96MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$355 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY3.67MShares$270 Million0.14% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.13MShares$156 Million0.07% of portfolio
-
State Street Corp Boston, MA1.8MShares$132 Million0.0% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.77B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...